BioNexus Gene Lab Corp (BGLC), headquartered in Kuala Lumpur, Malaysia, is an innovative biotechnology company focusing on cutting-edge genetic research and therapeutic solutions. Leveraging advanced gene editing and biomanufacturing techniques, BGLC is addressing key healthcare challenges while also enhancing agricultural productivity. With a robust product pipeline and a strong commitment to sustainability and regulatory adherence, BioNexus is well-positioned to capitalize on the increasing global demand for biotechnology advancements, promising significant growth in this dynamic sector.
Click "Analyze" to generate stock analysis
BGLC Price Trend and Signals
BGLC Financials
2025-12-17Somewhat Bearishprice_signal
Quarterly low detected.
2025-12-10Bullishmacd_signal
Golden cross below zero detected.
2025-12-05Somewhat Bearishprice_signal
Quarterly low detected.
2025-12-02Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-12-02Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-12-02Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-12-02Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-11-25Somewhat Bearishprice_signal
Monthly low detected.
2025-11-20Somewhat Bearishprice_signal
Monthly low detected.
2025-11-13Somewhat Bearishprice_signal
Monthly low detected.
2025-11-12Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-11-12Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-11-12Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-11-12Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.